Skip to main content

Medication & Treatment

People with diabetes use many medications to both manage blood sugar levels and also to prevent or treat health complications.

For people with type 1 diabetes, the most important drug is insulin; some people with type 2 diabetes also take insulin. For people with type 2 diabetes, glucose-lowering medications include metformin, sulfonylureas, TZDs, SGLT-2 inhibitors, GLP-1 agonists, DPP-4 inhibitors, and more.

Some of these drugs are injected, others are taken in pill form, and some are even inhaled. Learn about the different treatment options available and which might be best for your lifestyle.

Metformin
Insulin
SGLT-2 inhibitors
GLP-1 agonists
DPP-4 inhibitors
Combination drugs
Sulfonylureas (SFUs)
TZDs

What's new

Weight management is no easy task, but achieving and maintaining a healthy weight is important for your well-being, your diabetes management, and your overall health. Continue Reading »

The FDA and the FTC sent warning letters to 10 companies falsely claiming to sell dietary supplements that could cure, treat, mitigate, or prevent diabetes. People are strongly encouraged to avoid these products until they have undergone the proper testing. Continue Reading »

Kerendia (also known as finerenone) can reduce the risk of heart attacks, hospitalization for heart failure, and cardiovascular death for adults with chronic kidney disease in people with type 2 diabetes. Continue Reading »

​This international clinical trial is enrolling an estimated 1,224 participants who have been diagnosed with type 2 diabetes, age 18 or older. This study is investigating if higher doses of oral semaglutide (currently sold as Rybelsus) will lead to lower A1C levels.  Continue Reading »

Jardiance (empagliflozin), an SGLT-2 inhibitor, was recently approved by the FDA to help adults who have heart failure with reduced ejection fraction (HFrEF). Results from EMPEROR-Preserved also show Jardiance benefits those with heart failure with preserved ejection fraction (HFpEF). Continue Reading »

In this clinical trial, researchers are studying the effectiveness of dapagliflozin and saxagliptin in children and adolescents with type 2 diabetes. While these drugs are different, one is an SGLT-2 inhibitor and one is a DPP-4 inhibitor, and both have shown to lower blood glucose in adults with type 2 diabetes. Learn more about how to get involved. Continue Reading »

The Association of Diabetes Care and Education Specialists 2021 conference covered the impacts of diabetes stigma, smart MDI therapies, insulin delivery by means other than an insulin pump, the latest in diabetes tech, and more! Continue Reading »

When it comes to SGLT-2s and GLP-1s, there are several medicines available. Read below for more information on these therapies which have particular benefits for those with heart and/or kidney disease. Continue Reading »

Pages